nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.463	1	CpDpCtD
Etodolac—ALB—chronic obstructive pulmonary disease	0.196	1	CbGaD
Etodolac—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0569	0.347	CbGbCtD
Etodolac—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0302	0.184	CbGbCtD
Etodolac—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0302	0.184	CbGbCtD
Etodolac—ALB—Prednisone—chronic obstructive pulmonary disease	0.0235	0.144	CbGbCtD
Etodolac—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0229	0.14	CbGbCtD
Etodolac—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.00164	CcSEcCtD
Etodolac—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.00164	CcSEcCtD
Etodolac—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00164	CcSEcCtD
Etodolac—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00163	CcSEcCtD
Etodolac—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00163	CcSEcCtD
Etodolac—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00161	CcSEcCtD
Etodolac—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00161	CcSEcCtD
Etodolac—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00161	CcSEcCtD
Etodolac—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00161	CcSEcCtD
Etodolac—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00161	CcSEcCtD
Etodolac—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00161	CcSEcCtD
Etodolac—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.0016	CcSEcCtD
Etodolac—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000182	0.0016	CcSEcCtD
Etodolac—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00159	CcSEcCtD
Etodolac—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.00158	CcSEcCtD
Etodolac—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00018	0.00158	CcSEcCtD
Etodolac—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.00158	CcSEcCtD
Etodolac—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00018	0.00158	CcSEcCtD
Etodolac—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00158	CcSEcCtD
Etodolac—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00157	CcSEcCtD
Etodolac—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00157	CcSEcCtD
Etodolac—Infection—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00157	CcSEcCtD
Etodolac—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00155	CcSEcCtD
Etodolac—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00155	CcSEcCtD
Etodolac—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000177	0.00155	CcSEcCtD
Etodolac—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00155	CcSEcCtD
Etodolac—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.00155	CcSEcCtD
Etodolac—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00155	CcSEcCtD
Etodolac—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00155	CcSEcCtD
Etodolac—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00154	CcSEcCtD
Etodolac—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00154	CcSEcCtD
Etodolac—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00154	CcSEcCtD
Etodolac—Infection—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00154	CcSEcCtD
Etodolac—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000174	0.00153	CcSEcCtD
Etodolac—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00152	CcSEcCtD
Etodolac—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00151	CcSEcCtD
Etodolac—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00151	CcSEcCtD
Etodolac—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00151	CcSEcCtD
Etodolac—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00149	CcSEcCtD
Etodolac—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00149	CcSEcCtD
Etodolac—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00148	CcSEcCtD
Etodolac—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00147	CcSEcCtD
Etodolac—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00147	CcSEcCtD
Etodolac—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.00147	CcSEcCtD
Etodolac—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000167	0.00147	CcSEcCtD
Etodolac—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.00147	CcSEcCtD
Etodolac—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00145	CcSEcCtD
Etodolac—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.00144	CcSEcCtD
Etodolac—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00144	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00144	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00144	CcSEcCtD
Etodolac—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00143	CcSEcCtD
Etodolac—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00143	CcSEcCtD
Etodolac—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00142	CcSEcCtD
Etodolac—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.00142	CcSEcCtD
Etodolac—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00141	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00141	CcSEcCtD
Etodolac—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00016	0.00141	CcSEcCtD
Etodolac—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.00141	CcSEcCtD
Etodolac—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.0014	CcSEcCtD
Etodolac—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00016	0.0014	CcSEcCtD
Etodolac—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000159	0.0014	CcSEcCtD
Etodolac—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00139	CcSEcCtD
Etodolac—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00139	CcSEcCtD
Etodolac—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00139	CcSEcCtD
Etodolac—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00139	CcSEcCtD
Etodolac—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00139	CcSEcCtD
Etodolac—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000158	0.00138	CcSEcCtD
Etodolac—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00137	CcSEcCtD
Etodolac—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.00137	CcSEcCtD
Etodolac—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00136	CcSEcCtD
Etodolac—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00136	CcSEcCtD
Etodolac—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00136	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00136	CcSEcCtD
Etodolac—Pain—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00135	CcSEcCtD
Etodolac—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00135	CcSEcCtD
Etodolac—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00135	CcSEcCtD
Etodolac—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00135	CcSEcCtD
Etodolac—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00135	CcSEcCtD
Etodolac—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00134	CcSEcCtD
Etodolac—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000152	0.00133	CcSEcCtD
Etodolac—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00133	CcSEcCtD
Etodolac—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00132	CcSEcCtD
Etodolac—Pain—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00132	CcSEcCtD
Etodolac—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.00132	CcSEcCtD
Etodolac—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00015	0.00132	CcSEcCtD
Etodolac—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00131	CcSEcCtD
Etodolac—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00131	CcSEcCtD
Etodolac—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00131	CcSEcCtD
Etodolac—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000149	0.00131	CcSEcCtD
Etodolac—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000149	0.00131	CcSEcCtD
Etodolac—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.0013	CcSEcCtD
Etodolac—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000148	0.0013	CcSEcCtD
Etodolac—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.0013	CcSEcCtD
Etodolac—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.0013	CcSEcCtD
Etodolac—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00129	CcSEcCtD
Etodolac—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00129	CcSEcCtD
Etodolac—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00129	CcSEcCtD
Etodolac—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00129	CcSEcCtD
Etodolac—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00128	CcSEcCtD
Etodolac—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00127	CcSEcCtD
Etodolac—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00127	CcSEcCtD
Etodolac—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00126	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00126	CcSEcCtD
Etodolac—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00125	CcSEcCtD
Etodolac—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00125	CcSEcCtD
Etodolac—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00125	CcSEcCtD
Etodolac—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00125	CcSEcCtD
Etodolac—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00125	CcSEcCtD
Etodolac—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00125	CcSEcCtD
Etodolac—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000142	0.00124	CcSEcCtD
Etodolac—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.00123	CcSEcCtD
Etodolac—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.00123	CcSEcCtD
Etodolac—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00014	0.00123	CcSEcCtD
Etodolac—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00123	CcSEcCtD
Etodolac—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00123	CcSEcCtD
Etodolac—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.00122	CcSEcCtD
Etodolac—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000139	0.00122	CcSEcCtD
Etodolac—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000139	0.00122	CcSEcCtD
Etodolac—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00122	CcSEcCtD
Etodolac—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.00121	CcSEcCtD
Etodolac—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00121	CcSEcCtD
Etodolac—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.0012	CcSEcCtD
Etodolac—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00118	CcSEcCtD
Etodolac—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00118	CcSEcCtD
Etodolac—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00118	CcSEcCtD
Etodolac—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00116	CcSEcCtD
Etodolac—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00116	CcSEcCtD
Etodolac—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000132	0.00116	CcSEcCtD
Etodolac—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.00116	CcSEcCtD
Etodolac—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00013	0.00114	CcSEcCtD
Etodolac—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00113	CcSEcCtD
Etodolac—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00113	CcSEcCtD
Etodolac—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00112	CcSEcCtD
Etodolac—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00112	CcSEcCtD
Etodolac—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00111	CcSEcCtD
Etodolac—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000125	0.0011	CcSEcCtD
Etodolac—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.0011	CcSEcCtD
Etodolac—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00109	CcSEcCtD
Etodolac—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00108	CcSEcCtD
Etodolac—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00108	CcSEcCtD
Etodolac—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.00107	CcSEcCtD
Etodolac—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00107	CcSEcCtD
Etodolac—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00107	CcSEcCtD
Etodolac—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00106	CcSEcCtD
Etodolac—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00105	CcSEcCtD
Etodolac—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00104	CcSEcCtD
Etodolac—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00104	CcSEcCtD
Etodolac—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000116	0.00102	CcSEcCtD
Etodolac—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00102	CcSEcCtD
Etodolac—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00102	CcSEcCtD
Etodolac—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000114	0.001	CcSEcCtD
Etodolac—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.001	CcSEcCtD
Etodolac—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000995	CcSEcCtD
Etodolac—Rash—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000995	CcSEcCtD
Etodolac—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000994	CcSEcCtD
Etodolac—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000994	CcSEcCtD
Etodolac—Headache—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000988	CcSEcCtD
Etodolac—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000988	CcSEcCtD
Etodolac—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000987	CcSEcCtD
Etodolac—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000985	CcSEcCtD
Etodolac—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000985	CcSEcCtD
Etodolac—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000112	0.000982	CcSEcCtD
Etodolac—Rash—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000974	CcSEcCtD
Etodolac—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000973	CcSEcCtD
Etodolac—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000971	CcSEcCtD
Etodolac—Headache—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000968	CcSEcCtD
Etodolac—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00096	CcSEcCtD
Etodolac—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000957	CcSEcCtD
Etodolac—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000954	CcSEcCtD
Etodolac—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000947	CcSEcCtD
Etodolac—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000944	CcSEcCtD
Etodolac—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000941	CcSEcCtD
Etodolac—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000939	CcSEcCtD
Etodolac—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000939	CcSEcCtD
Etodolac—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000938	CcSEcCtD
Etodolac—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000937	CcSEcCtD
Etodolac—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000937	CcSEcCtD
Etodolac—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000933	CcSEcCtD
Etodolac—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00092	CcSEcCtD
Etodolac—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000918	CcSEcCtD
Etodolac—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000907	CcSEcCtD
Etodolac—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000904	CcSEcCtD
Etodolac—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000885	CcSEcCtD
Etodolac—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.000881	CcSEcCtD
Etodolac—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000878	CcSEcCtD
Etodolac—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.000874	CcSEcCtD
Etodolac—Hallucination—Prednisone—chronic obstructive pulmonary disease	9.91e-05	0.000869	CcSEcCtD
Etodolac—Oedema—Prednisolone—chronic obstructive pulmonary disease	9.74e-05	0.000854	CcSEcCtD
Etodolac—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	9.74e-05	0.000854	CcSEcCtD
Etodolac—Shock—Prednisolone—chronic obstructive pulmonary disease	9.58e-05	0.000841	CcSEcCtD
Etodolac—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.5e-05	0.000834	CcSEcCtD
Etodolac—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.41e-05	0.000826	CcSEcCtD
Etodolac—Flushing—Prednisone—chronic obstructive pulmonary disease	9.24e-05	0.000811	CcSEcCtD
Etodolac—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	8.9e-05	0.000781	CcSEcCtD
Etodolac—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.81e-05	0.000773	CcSEcCtD
Etodolac—Alopecia—Prednisone—chronic obstructive pulmonary disease	8.8e-05	0.000772	CcSEcCtD
Etodolac—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	8.74e-05	0.000767	CcSEcCtD
Etodolac—Pain—Prednisolone—chronic obstructive pulmonary disease	8.33e-05	0.000731	CcSEcCtD
Etodolac—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.17e-05	0.000717	CcSEcCtD
Etodolac—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.04e-05	0.000706	CcSEcCtD
Etodolac—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.02e-05	0.000704	CcSEcCtD
Etodolac—Anaemia—Prednisone—chronic obstructive pulmonary disease	8.01e-05	0.000703	CcSEcCtD
Etodolac—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.92e-05	0.000695	CcSEcCtD
Etodolac—Malaise—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000686	CcSEcCtD
Etodolac—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.79e-05	0.000683	CcSEcCtD
Etodolac—Syncope—Prednisone—chronic obstructive pulmonary disease	7.78e-05	0.000682	CcSEcCtD
Etodolac—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.74e-05	0.000679	CcSEcCtD
Etodolac—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.62e-05	0.000669	CcSEcCtD
Etodolac—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.51e-05	0.000659	CcSEcCtD
Etodolac—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.49e-05	0.000657	CcSEcCtD
Etodolac—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.38e-05	0.000648	CcSEcCtD
Etodolac—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.38e-05	0.000648	CcSEcCtD
Etodolac—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.36e-05	0.000645	CcSEcCtD
Etodolac—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.29e-05	0.00064	CcSEcCtD
Etodolac—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.17e-05	0.000629	CcSEcCtD
Etodolac—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.08e-05	0.000621	CcSEcCtD
Etodolac—Oedema—Prednisone—chronic obstructive pulmonary disease	7.08e-05	0.000621	CcSEcCtD
Etodolac—Infection—Prednisone—chronic obstructive pulmonary disease	7.03e-05	0.000617	CcSEcCtD
Etodolac—Shock—Prednisone—chronic obstructive pulmonary disease	6.96e-05	0.000611	CcSEcCtD
Etodolac—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.000606	CcSEcCtD
Etodolac—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.84e-05	0.0006	CcSEcCtD
Etodolac—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.74e-05	0.000592	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.000566	CcSEcCtD
Etodolac—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.44e-05	0.000565	CcSEcCtD
Etodolac—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.4e-05	0.000562	CcSEcCtD
Etodolac—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.000557	CcSEcCtD
Etodolac—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.000546	CcSEcCtD
Etodolac—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.15e-05	0.00054	CcSEcCtD
Etodolac—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.14e-05	0.000972	CbGpPWpGaD
Etodolac—Rash—Prednisolone—chronic obstructive pulmonary disease	6.14e-05	0.000539	CcSEcCtD
Etodolac—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.13e-05	0.000538	CcSEcCtD
Etodolac—UGT1A9—Metabolism—APIP—chronic obstructive pulmonary disease	6.12e-05	0.000969	CbGpPWpGaD
Etodolac—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.1e-05	0.000535	CcSEcCtD
Etodolac—Headache—Prednisolone—chronic obstructive pulmonary disease	6.1e-05	0.000535	CcSEcCtD
Etodolac—Constipation—Prednisone—chronic obstructive pulmonary disease	6.05e-05	0.000531	CcSEcCtD
Etodolac—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	6.04e-05	0.000956	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	5.99e-05	0.000949	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	5.96e-05	0.000944	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	5.96e-05	0.000944	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.87e-05	0.000929	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	5.87e-05	0.000929	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	5.84e-05	0.000925	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	5.84e-05	0.000924	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	5.83e-05	0.000923	CbGpPWpGaD
Etodolac—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.83e-05	0.000512	CcSEcCtD
Etodolac—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.79e-05	0.000508	CcSEcCtD
Etodolac—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.78e-05	0.000507	CcSEcCtD
Etodolac—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	5.78e-05	0.000915	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	5.74e-05	0.000908	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.73e-05	0.000908	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	5.72e-05	0.000906	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GC—chronic obstructive pulmonary disease	5.71e-05	0.000904	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.68e-05	0.000899	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	5.66e-05	0.000896	CbGpPWpGaD
Etodolac—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.62e-05	0.000493	CcSEcCtD
Etodolac—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000491	CcSEcCtD
Etodolac—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000491	CcSEcCtD
Etodolac—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.4e-05	0.000855	CbGpPWpGaD
Etodolac—UGT1A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.4e-05	0.000855	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	5.39e-05	0.000853	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.34e-05	0.000845	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	5.31e-05	0.000841	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.31e-05	0.000841	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	5.25e-05	0.000831	CbGpPWpGaD
Etodolac—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	5.24e-05	0.000829	CbGpPWpGaD
Etodolac—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.21e-05	0.000457	CcSEcCtD
Etodolac—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.08e-05	0.000445	CcSEcCtD
Etodolac—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	5.06e-05	0.000801	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.01e-05	0.000793	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	5.01e-05	0.000793	CbGpPWpGaD
Etodolac—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.000439	CcSEcCtD
Etodolac—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	4.99e-05	0.00079	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.99e-05	0.00079	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GC—chronic obstructive pulmonary disease	4.86e-05	0.000769	CbGpPWpGaD
Etodolac—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000425	CcSEcCtD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	4.77e-05	0.000755	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	4.74e-05	0.000751	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	4.7e-05	0.000744	CbGpPWpGaD
Etodolac—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.000411	CcSEcCtD
Etodolac—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	4.66e-05	0.000737	CbGpPWpGaD
Etodolac—RXRA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.66e-05	0.000737	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	4.64e-05	0.000734	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.64e-05	0.000734	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.62e-05	0.000731	CbGpPWpGaD
Etodolac—UGT2B7—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.59e-05	0.000727	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GC—chronic obstructive pulmonary disease	4.53e-05	0.000717	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.51e-05	0.000715	CbGpPWpGaD
Etodolac—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.5e-05	0.000395	CcSEcCtD
Etodolac—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.49e-05	0.000711	CbGpPWpGaD
Etodolac—Rash—Prednisone—chronic obstructive pulmonary disease	4.46e-05	0.000391	CcSEcCtD
Etodolac—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.46e-05	0.000391	CcSEcCtD
Etodolac—Headache—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000389	CcSEcCtD
Etodolac—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.43e-05	0.000701	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—TNF—chronic obstructive pulmonary disease	4.39e-05	0.000695	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.37e-05	0.000691	CbGpPWpGaD
Etodolac—RXRA—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.28e-05	0.000678	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.26e-05	0.000674	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	4.23e-05	0.00067	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.21e-05	0.000667	CbGpPWpGaD
Etodolac—Nausea—Prednisone—chronic obstructive pulmonary disease	4.2e-05	0.000369	CcSEcCtD
Etodolac—UGT1A9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.06e-05	0.000642	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.02e-05	0.000637	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	3.96e-05	0.000627	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GC—chronic obstructive pulmonary disease	3.95e-05	0.000625	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	3.84e-05	0.000608	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.8e-05	0.000601	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	3.77e-05	0.000597	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.76e-05	0.000596	CbGpPWpGaD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.74e-05	0.000593	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.74e-05	0.000593	CbGpPWpGaD
Etodolac—UGT1A9—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.73e-05	0.000591	CbGpPWpGaD
Etodolac—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.69e-05	0.000585	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	3.68e-05	0.000583	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.67e-05	0.000581	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.61e-05	0.000572	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.56e-05	0.000563	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—IL6—chronic obstructive pulmonary disease	3.54e-05	0.000561	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	3.47e-05	0.00055	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.45e-05	0.000547	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	3.44e-05	0.000545	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	3.44e-05	0.000545	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.44e-05	0.000545	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.44e-05	0.000544	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	3.41e-05	0.000541	CbGpPWpGaD
Etodolac—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.39e-05	0.000537	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.39e-05	0.000536	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.38e-05	0.000535	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.36e-05	0.000531	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.31e-05	0.000523	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	3.28e-05	0.000519	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.28e-05	0.000519	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.26e-05	0.000516	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—LEP—chronic obstructive pulmonary disease	3.26e-05	0.000516	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.23e-05	0.000511	CbGpPWpGaD
Etodolac—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.22e-05	0.000509	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	3.22e-05	0.000509	CbGpPWpGaD
Etodolac—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	3.21e-05	0.000508	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.17e-05	0.000502	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	3.16e-05	0.0005	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.12e-05	0.000494	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GCLC—chronic obstructive pulmonary disease	3.08e-05	0.000488	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	3.04e-05	0.00048	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	3.01e-05	0.000477	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	3.01e-05	0.000476	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.99e-05	0.000473	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.92e-05	0.000463	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—CTGF—chronic obstructive pulmonary disease	2.87e-05	0.000454	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	2.86e-05	0.000453	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.84e-05	0.00045	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.83e-05	0.000447	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CTGF—chronic obstructive pulmonary disease	2.81e-05	0.000446	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	2.81e-05	0.000444	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	2.78e-05	0.00044	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.74e-05	0.000433	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.73e-05	0.000432	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.72e-05	0.00043	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.68e-05	0.000423	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	2.67e-05	0.000423	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.65e-05	0.00042	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.63e-05	0.000416	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.62e-05	0.000415	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.62e-05	0.000415	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.61e-05	0.000413	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.6e-05	0.000412	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.59e-05	0.00041	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	2.55e-05	0.000404	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.47e-05	0.000392	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GCLC—chronic obstructive pulmonary disease	2.45e-05	0.000387	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.39e-05	0.000379	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.38e-05	0.000377	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.37e-05	0.000376	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	2.36e-05	0.000373	CbGpPWpGaD
Etodolac—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.34e-05	0.00037	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.29e-05	0.000362	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.28e-05	0.000361	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CTGF—chronic obstructive pulmonary disease	2.23e-05	0.000353	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.22e-05	0.000352	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.21e-05	0.000349	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.2e-05	0.000349	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.17e-05	0.000343	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.16e-05	0.000342	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	2.16e-05	0.000342	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.16e-05	0.000341	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.13e-05	0.000338	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.13e-05	0.000337	CbGpPWpGaD
Etodolac—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.12e-05	0.000336	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.12e-05	0.000336	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.11e-05	0.000334	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.11e-05	0.000333	CbGpPWpGaD
Etodolac—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.07e-05	0.000327	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.06e-05	0.000326	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.99e-05	0.000315	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.99e-05	0.000315	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.96e-05	0.00031	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.95e-05	0.000308	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.94e-05	0.000308	CbGpPWpGaD
Etodolac—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.92e-05	0.000304	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.91e-05	0.000302	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.9e-05	0.000301	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.89e-05	0.000299	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.88e-05	0.000298	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.87e-05	0.000296	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.84e-05	0.000291	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.82e-05	0.000288	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.81e-05	0.000287	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.79e-05	0.000284	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.76e-05	0.000279	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.76e-05	0.000278	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.74e-05	0.000275	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.74e-05	0.000275	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.72e-05	0.000273	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.72e-05	0.000272	CbGpPWpGaD
Etodolac—RXRA—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.69e-05	0.000268	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.69e-05	0.000268	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.69e-05	0.000268	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.65e-05	0.000261	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.62e-05	0.000256	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.62e-05	0.000256	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.6e-05	0.000254	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.6e-05	0.000254	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.59e-05	0.000251	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.58e-05	0.000251	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.58e-05	0.00025	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.57e-05	0.000249	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.53e-05	0.000242	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.53e-05	0.000242	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.51e-05	0.000239	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.51e-05	0.000239	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.49e-05	0.000237	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.49e-05	0.000237	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.48e-05	0.000234	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.47e-05	0.000233	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.46e-05	0.000231	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.4e-05	0.000222	CbGpPWpGaD
Etodolac—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	1.4e-05	0.000222	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.4e-05	0.000221	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.38e-05	0.000218	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.37e-05	0.000217	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.36e-05	0.000215	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.31e-05	0.000207	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.3e-05	0.000206	CbGpPWpGaD
Etodolac—PTGS2—Disease—KL—chronic obstructive pulmonary disease	1.3e-05	0.000206	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.29e-05	0.000204	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ALB—chronic obstructive pulmonary disease	1.28e-05	0.000203	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.26e-05	0.000199	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.25e-05	0.000198	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.23e-05	0.000194	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.22e-05	0.000193	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.22e-05	0.000193	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.2e-05	0.00019	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.16e-05	0.000184	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.14e-05	0.000181	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.13e-05	0.000179	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.12e-05	0.000177	CbGpPWpGaD
Etodolac—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.12e-05	0.000177	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.09e-05	0.000173	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	1.09e-05	0.000172	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.06e-05	0.000168	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.04e-05	0.000165	CbGpPWpGaD
Etodolac—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.02e-05	0.000161	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ALB—chronic obstructive pulmonary disease	1.02e-05	0.000161	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	9.76e-06	0.000154	CbGpPWpGaD
Etodolac—RXRA—Metabolism—NOS3—chronic obstructive pulmonary disease	9.72e-06	0.000154	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.67e-06	0.000153	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.54e-06	0.000151	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.38e-06	0.000148	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.24e-06	0.000146	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.13e-06	0.000145	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.89e-06	0.000141	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	8.85e-06	0.00014	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.52e-06	0.000135	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	8.46e-06	0.000134	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.42e-06	0.000133	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	8.33e-06	0.000132	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	8.14e-06	0.000129	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	7.88e-06	0.000125	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.82e-06	0.000124	CbGpPWpGaD
Etodolac—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.72e-06	0.000122	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.68e-06	0.000122	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.23e-06	0.000114	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	7.21e-06	0.000114	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.19e-06	0.000114	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.9e-06	0.000109	CbGpPWpGaD
Etodolac—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	6.85e-06	0.000108	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.82e-06	0.000108	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	6.54e-06	0.000104	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.4e-06	0.000101	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.32e-06	0.0001	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	5.95e-06	9.42e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.89e-06	9.32e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	5.73e-06	9.06e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.58e-06	8.83e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.48e-06	8.67e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	4.43e-06	7.02e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	4.33e-06	6.85e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	4.24e-06	6.71e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.79e-06	6e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.63e-06	5.74e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	3.26e-06	5.16e-05	CbGpPWpGaD
